Class: Extraction/Preservation (153)
Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
Patent Number: 6569427This patent covers the use of cord blood cells. Any cord blood bank in the US has to license this patent or else Pharmastem will litigate as they have in the past.
Inventors: Boyse, Edward A. (Tucson, AZ); Broxmeyer, Hal E. (Indianapolis, IN); Douglas, Gordon W. (New York, NY)
Assignee: PharmaStem Therapeutics, Inc. (Del Mar, CA)
Date of First Priority Issue: Thursday November 12th, 1987
Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
Patent Number: 5192553This is a patent on freezing cord blood stem cells. This is an important patent since it is generating revenue. The company Pharmastem used this patent and several others in order to position itself in the cord blood industry. Additionally, this patent stood the test of litigation.
Inventors: Boyse, Edward A. (Tucson, AZ); Broxmeyer, Hal E. (Indianapolis, IN); Douglas, Gordon W. (New York, NY)
Assignee: Biocyte Corporation (New York, NY)
Date of First Priority Issue: Thursday November 12th, 1987
Composition and method for supporting bone marrow transplantation
Patent Number: 5186931This patent provides a composition of cytokines for stimulating hematopoiesis after a bone marrow transplant, as well as for the in vitro stimulation of hematopoiesis. The composition involves B cell differentiation factor and some commonly used cytokines today.
Inventors: Kishimoto, Tadamitsu (Nakano Tondabayashi-shi, Oosaka-fu, JP); Hirano, Toshio (Ibaraki, JP); Akiyama, Yukio (Kawasaki, JP); Okano, Akira (Kawasaki, JP); Matsui, Hiroshi (Kawasaki, JP); Takahara, Yoshiyuki (Kawasaki, JP)
Assignee: Ajinomoto Co., Inc. (Tokyo, JP) Kishimoto, Tadamitsu (Tondabayashi, JP)
Date of First Priority Issue: Wednesday August 6th, 1986